US cardiology market price
2023
US $16.67 billion
2030
US $25.60 billion
CAGR (compound annual growth rate)
6.32%
(2024-2030)
Cardiovascular disease (CVD)
#1 reason for death in the U.S.
Market increasers
Upward growth in cardiovascular sickness due to:
- Weight problems
- High blood pressure
- Diabetes
Technology advancements
Minimally invasive methods
Imagining techniques
Material advancements
Wearables
Remote monitoring
Benefits of technology advancements
Enhance patient results
Lessen healing times
Increase efficiency of cardiovascular treatments
Technology used ranges from echocardiography machines and stress tests to catheterization labs.
Key players in the cardiovascular market
Abbott Laboratories
Boston Scientific Corp.
Edwards Lifesciences
Cardinal Health Inc.
Medtronic PLC
GE Healthcare
Johnson & Johnson Services, Inc.
Siemens Healthcare GmbH
https://www.researchandmarkets.com/report/united-states-cardiovascular-devices-market
ICONS: ADOBE STOCK
Explore the May 2024 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Low-profile power supplies for medical device miniaturization
- The top performer in medical device regulation: Singapore
- Sandvik Coromant expands CoroDrill DE10 drill line
- #84 Manufacturing Matters - Defense Industry Trends with Greenwich Capital Group
- Case study: Transforming CNC machining through smart lubrication strategies
- Join the automation conversation
- Medtronic expands neurovascular portfolio with Scientia acquisition
- Enhanced visitor experience highlighted at TMTS 2026
